Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation

This publication has 22 references indexed in Scilit:

• Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides
  Journal of Controlled Release, 1997
• Synthesis and evaluation of a modified mucoadhesive polymer protecting from α-chymotrypsinic degradation
  International Journal of Pharmaceutics, 1997
• Novel Bioadhesive Chitosan-EDTA Conjugate Protects Leucine Enkephalin from Degradation by Aminopeptidase N
  Pharmaceutical Research, 1997
• Development and Analysis of a Polymer Protecting from Luminal Enzymatic Degradation Caused by α-Chymotrypsin
  Drug Development and Industrial Pharmacy, 1997
• Development and in Vitro Evaluation of Systems to Protect Peptide Drugs from Aminopeptidase N
  Pharmaceutical Research, 1997
• Novel peroral dosage forms with protease inhibitory activities. II. Design of fast dissolving poly(acrylate) and controlled drug-releasing capsule formulations with trypsin inhibiting properties
  International Journal of Pharmaceutics, 1996
• Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation
  International Journal of Pharmaceutics, 1996
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
  Pharmaceutical Research, 1994
• Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects
  Antimicrobial Agents and Chemotherapy, 1992
• Transit of pharmaceutical dosage forms through the small intestine.
  Gut, 1986